SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-12-057005
Filing Date
2012-10-19
Accepted
2012-10-19 16:09:44
Documents
4
Period of Report
2012-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v326086_10ka.htm 10-K/A 276896
2 EXHIBIT 31.1 v326086_ex31-1.htm EX-31.1 9308
3 EXHIBIT 31.2 v326086_ex31-2.htm EX-31.2 9315
4 EXHIBIT 32 v326086_ex32.htm EX-32 4560
  Complete submission text file 0001144204-12-057005.txt   301115
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 000-25169 | Film No.: 121152554
SIC: 2834 Pharmaceutical Preparations